No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
PAVMZ Pavmed Inc C/Wts 30/04/2024(To Pur Com) Class Z
- 0.0309
- +0.0108+53.73%
Close Apr 26 16:00 ET
412.30KMarket Cap0.00P/E (TTM)
0.0335High0.0200Low9.15KVolume0.0335Open0.0201Pre Close267.58Turnover0.07%Turnover Ratio0.00P/E (Static)13.34MShares0.272052wk High0.00P/B412.30KFloat Cap0.001252wk Low--Dividend TTM13.34MShs Float8.0700Historical High--Div YieldTTM67.16%Amplitude0.0012Historical Low0.0290Avg Price1Lot Size
Post-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Buy Rating Affirmed for PAVmed on Growth and Valuation Prospects Amidst Product Commercialization
Why PAVmed Inc. (PAVM) Dipped More Than Broader Market Today
Lucid Diagnostics to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
Buy Rating Affirmed for PAVmed With Strategic Focus on Lucid Diagnostics and Veris Cancer Care Amid Adjusted Price Target
PAVmed Inc. (NASDAQ:PAVM) Q4 2023 Earnings Call Transcript
Analysts Offer Insights on Healthcare Companies: PAVmed (PAVM) and Simulations Plus (SLP)
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg